Genmab — August 2023

[Stroka]

God morgen

[bibob]

God morgen.

[E_L]

venetoclax is from AbbVie, isn't it. There is also this epcoritamab + venetoclax trial https://classic.clinicaltrials.gov/ct2/show/NCT05791409

[Bulder]

Yes it is AbbVie. Venclyxto.

[Bulder]

Hm, ser vi bort fra Bava er det medicinal på taberlisten i dag.

[lahn1]

Groundhog day

[JKY_VH]

"Den fede dame" har ikke sunget endnu Bulder;-)

[Riis7]

Man kan ikke bruge den us kurs til meget,
åbner altid under i dk:-)

[Bulder]

Næh, synes bare at jeg øjnede et halmstrå i de grønne farma-aktier i us i går. Og at det så skulle være overstået. Men futterne dykker igen. Trist.

[Riis7]

vejret og aktierne er triste i dag:-)

[Bulder]

Spændende om vi får lidt mere at vide om innova tecvayli 301 i dag, siden de nu venter topline resultater allerede i år. Måske vil en godkendelse kunne nås til næste år, og så har vi Tivdak i 2. linje.

[Bulder]

Ipad rettede TV til tecvayli

[E_L]

yes, we would really need to get further up the line to see additional revenue, and hopefully some data on other tumors

[E_L]

further not that much to expect this evening i guess... even though we should expect genmab at some point to mention something about GEN1047 DuoBody-CD3xB7H4

and GEN3009 DuoHexabody-CD37
; they will have to make a decision at some point to continue or not

[Bulder]

And also a confimation that we can expect data from 1042 and 1046 this year.

[Bulder]

Right now an announcement that jnj has chosen to opt in on hex38 would be very useful.

[Sukkeralf]

Also a BL.A. in immunology with one of Genmabs own antibodies maybe

[E_L]

I think champagne consumption would show a nice spike in Denmark this evening in that case ;-). 0% chance is my guess

[Bulder]

Så røg gen da i det mindste ud af top 7 på taberlisten.

[E_L]

That was on Bulder. A BLA indeed has
a chance and would also be very welcome